Skip to content
PubMed This is a summary of 11 peer-reviewed journal articles Updated
Medical Genetics · SAMD9L-associated autoinflammatory disease

Decoding Diagnosis and Pathology Reports

At a Glance

SAMD9L-associated autoinflammatory disease can be hidden by genetic rescue in blood cells. If blood testing is negative or unclear, doctors may use skin fibroblasts and interpret blood counts, bone marrow, immune tests, and chromosome 7 findings together.

Navigating pathology and genetics reports for SAMD9L-associated autoinflammatory disease (SAAD) can feel like learning a foreign language. These reports contain the “roadmap” for your child’s care, detailing how the genetic change is affecting their blood and immune system. Because this condition can “hide” in the blood, the type of sample tested is just as important as the results themselves [1][2].

Why Blood Tests Are Sometimes Insufficient

The most critical thing to know about diagnosing SAMD9L is that a blood test alone may be misleading. As covered in the biology page, the body often attempts Somatic Genetic Rescue (SGR)—a process where blood cells “fix” the mutation so they can grow better [3][4].

Blood is often an appropriate first-line sample and can successfully provide a diagnosis. However, if a lab only tests a blood sample and rescue has occurred, the “rescued” healthy cells might outnumber the “original” mutated cells. This can make the mutation look less severe than it is, or even make it disappear entirely from the report [1][2]. To get a true “germline” diagnosis (the DNA your child was born with) when blood testing is negative or uncertain, doctors test non-hematopoietic tissue—tissue that doesn’t come from the blood-making system.

  • Skin Fibroblasts: A small skin biopsy is considered the preferred confirmatory tissue because cultured skin cells do not undergo the same rescue process as blood cells [2][5].
  • Saliva or Buccal Swabs: These are often used as an alternative, though they can sometimes be contaminated with “rescued” white blood cells and are not strictly equivalent [2].

Decoding Your Child’s Reports

When you look at a laboratory report, you will likely encounter several technical terms that describe the state of your child’s bone marrow and immune system:

  • Variant Allele Fraction (VAF): This is the proportion of sequencing reads carrying a variant, not simply a direct percentage of cells carrying a variant. VAF can be affected by zygosity, mosaicism, and copy-number changes, and it requires clinical-genetics interpretation [1].
  • Variant Classifications: Findings are classified as Pathogenic (disease-causing), Likely Pathogenic, or a Variant of Uncertain Significance (VUS) (insufficient evidence to know if it causes disease) [6].
  • Hypocellularity: This means the bone marrow has fewer blood-forming cells than expected for your child’s age. It is a sign that the “stuck brake” of the SAMD9L mutation is slowing down cell production [1][4].
  • B-cell Paucity: This indicates a very low number of B cells, which are white blood cells that make antibodies to fight infections. This can lead to an increased risk of getting sick [4][7].
  • Elevated Interferon Signature: This is a sign of high-level inflammation. It means the body is acting as if it is fighting a permanent virus, even when no infection is present [7][4].
  • Panniculitis: In a pathology report for a skin biopsy, this refers to inflammation in the fat layer under the skin, which appears as painful red bumps [7].
  • Monosomy 7 / UPD7q: These describe different types of “rescue” events happening in the marrow. Monosomy 7 (detected by FISH or cytogenetics) is a high-risk clonal abnormality requiring expert interpretation in context. UPD7q (copy-neutral loss of heterozygosity) generally requires an SNP array or microarray rather than routine FISH [1][3][8].

Potential Components Checklist

A complete diagnostic workup for SAMD9L is not one-size-fits-all. The following are possible components selected by genetics, hematology, immunology, and neurology teams based on your child’s symptoms:

1. The Genetic Foundation

  • [ ] Germline Testing: SAMD9L sequencing, potentially on a non-blood sample (skin) if needed [2].
  • [ ] Variant Allele Fraction (VAF): A sequencing proportion that helps identify if rescue is happening [1].
  • [ ] Somatic Rescue Assessment: Testing for secondary mutations (in cis) or UPD7q [4][6].

2. The Bone Marrow & Blood

  • [ ] CBC with Differential: Showing the Absolute Neutrophil Count (ANC), hemoglobin, and platelets [1].
  • [ ] Bone Marrow Aspirate/Biopsy: Checking for cellularity (how many cells are there) and dysplasia (if cells look abnormal) [1][4].
  • [ ] FISH/Cytogenetics for Chromosome 7: Specifically looking for Monosomy 7 or 7q deletions [1][8].

3. The Immune & Inflammatory Status

  • [ ] Lymphocyte Subsets: Detailed counts of B cells, T cells, and NK cells [9].
  • [ ] Inflammatory Markers: Tests like CRP or an Interferon Signature to measure background inflammation [7].

4. Neurologic Baseline

  • [ ] Neurologic Exam: A baseline assessment of balance, coordination (ataxia), and eye movement (nystagmus) [10][11].
  • [ ] Brain MRI: Symptom-directed imaging to check for cerebellar atrophy or basal ganglia calcifications [10].

By ensuring your child’s records include these data points, you can help your care team monitor whether the disease is staying stable, progressing, or moving toward a “rescue” remission [8][4].

Common questions in this guide

Can a blood test be negative even if my child has a SAMD9L change?
Yes. Blood-forming cells can undergo somatic genetic rescue, allowing cells without the original change to become more common and making the change appear less significant or undetectable. If blood results are negative or unclear, the care team may test non-blood tissue, often cultured skin fibroblasts.
Why might doctors test skin cells instead of relying on blood?
Cultured skin fibroblasts are a preferred confirmatory sample because they do not undergo the same blood-cell rescue process. Saliva or cheek-cell testing may be an alternative, but white-blood-cell contamination can make those results less equivalent.
What does VAF mean on a SAMD9L genetic report?
Variant allele fraction, or VAF, is the proportion of sequencing reads that contain a genetic change; it is not a direct count of the percentage of cells carrying it. Its meaning depends on factors such as whether one or both gene copies are affected, mosaicism, and copy-number changes, so a clinical genetics professional should interpret it.
What do hypocellularity and a low B-cell count mean in my child’s reports?
Hypocellularity means the bone marrow has fewer blood-forming cells than expected for the child’s age. A low B-cell count means there are fewer antibody-producing white blood cells and may increase infection risk; both findings should be interpreted with the rest of the blood, marrow, and immune results.
Does monosomy 7 automatically mean my child is developing MDS?
No, a monosomy 7 result cannot be interpreted by itself. In SAMD9L-associated disease, it is a high-risk clonal abnormality that may be related to a rescue process, but its significance depends on the marrow findings, other chromosome results, blood counts, and clinical course.
What tests may be included in a SAMD9L evaluation?
Depending on symptoms, clinicians may order germline SAMD9L testing, a complete blood count, bone marrow examination, chromosome 7 studies, immune-cell counts, and inflammation tests. A neurologic examination or brain MRI may be added when symptoms or baseline monitoring call for it.
What is the difference between monosomy 7 and UPD7q?
Monosomy 7 means a cell has lost one copy of chromosome 7, while UPD7q is a copy-neutral change involving the long arm of chromosome 7. Monosomy 7 is usually assessed with FISH or cytogenetics, whereas UPD7q generally requires an SNP array or microarray, and both findings need specialist interpretation.

Get notified when new evidence is published on SAMD9L-associated autoinflammatory syndrome.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

References

References (11)
  1. 1

    Constitutional SAMD9L mutations cause familial myelodysplastic syndrome and transient monosomy 7.

    Pastor VB, Sahoo SS, Boklan J, et al.

    Haematologica 2018; (103(3)):427-437 doi:10.3324/haematol.2017.180778.

    PMID: 29217778
  2. 2

    From a novel pathogenic SAMD9L variant to cohort-wide insights: Whole-genome sequencing highlights somatic genetic rescue and phenotypic heterogeneity.

    Dellal H, Klifa R, Larcher L, et al.

    British journal of haematology 2026; (209(1)):75-83 doi:10.1111/bjh.70563.

    PMID: 42154215
  3. 3

    Gain-of-function SAMD9L mutations cause a syndrome of cytopenia, immunodeficiency, MDS, and neurological symptoms.

    Tesi B, Davidsson J, Voss M, et al.

    Blood 2017; (129(16)):2266-2279 doi:10.1182/blood-2016-10-743302.

    PMID: 28202457
  4. 4

    Genetic and clinical spectrum of SAMD9 and SAMD9L syndromes: from variant interpretation to patient management.

    Sahoo SS, Erlacher M, Wlodarski MW

    Blood 2025; (145(5)):475-485 doi:10.1182/blood.2022017717.

    PMID: 39475954
  5. 5

    Moving Beyond Somatic Alterations: Uncovering the Germline Basis of Myeloid Malignancies.

    Elbaz Younes I, Nguyen L, Zhang L

    Cancers 2026; (18(2)) doi:10.3390/cancers18020240.

    PMID: 41595160
  6. 6

    Of gains and losses: SAMD9/SAMD9L and monosomy 7 in myelodysplastic syndrome.

    Cammenga J

    Experimental hematology 2024; (134()):104217 doi:10.1016/j.exphem.2024.104217.

    PMID: 38649131
  7. 7

    Distinct interferon signatures and cytokine patterns define additional systemic autoinflammatory diseases.

    de Jesus AA, Hou Y, Brooks S, et al.

    The Journal of clinical investigation 2020; (130(4)):1669-1682.

    PMID: 31874111
  8. 8

    Spontaneous remission and loss of monosomy 7: a window of opportunity for young children with SAMD9L syndrome.

    Erlacher M, Andresen F, Sukova M, et al.

    Haematologica 2024; (109(2)):422-430 doi:10.3324/haematol.2023.283591.

    PMID: 37584291
  9. 9

    SAMD9L autoinflammatory or ataxia pancytopenia disease mutations activate cell-autonomous translational repression.

    Russell AJ, Gray PE, Ziegler JB, et al.

    Proceedings of the National Academy of Sciences of the United States of America 2021; (118(34)) doi:10.1073/pnas.2110190118.

    PMID: 34417303
  10. 10

    Ataxia-pancytopenia syndrome with SAMD9L mutations.

    Gorcenco S, Komulainen-Ebrahim J, Nordborg K, et al.

    Neurology. Genetics 2017; (3(5)):e183 doi:10.1212/NXG.0000000000000183.

    PMID: 28852709
  11. 11

    Assessing Long-Term Neurologic Outcomes in SAMD9L-Related Ataxia-Pancytopenia Syndrome.

    Zingariello CD, Chen DH, Raskind WH, et al.

    Movement disorders clinical practice 2024; (11(6)):728-733 doi:10.1002/mdc3.14038.

    PMID: 38594844

This page is for informational purposes only and does not constitute medical advice. Your child’s genetics, hematology, immunology, and neurology teams should interpret the reports and guide care.